Ask three people what “GMP” means and you may get three answers. Yet for any peptide heading toward the clinic, GMP is the difference between material you can file with and material you cannot. This guide explains GMP and quality in peptide manufacturing in plain English — what it is, what it involves, and how a program moves through it.
What is GMP (and cGMP)?
Good Manufacturing Practice (GMP) is a system of regulations and expectations ensuring that products are consistently produced and controlled to quality standards appropriate for their intended use. “cGMP” — current GMP — emphasises that those standards evolve. Crucially, GMP is not a purity grade; it is a quality system, as we explain in research grade vs GMP peptides. GMP peptide manufacturing applies this system to peptide production.
The pillars of a GMP quality system
- Defined, validated processes that produce consistent results.
- Quality control — testing against specifications by validated methods.
- Quality assurance — the oversight that the system is followed.
- Documentation — if it isn’t written down, it didn’t happen.
- Data integrity — trustworthy records, covered in audit-ready data integrity.
- Traceability — from raw material to released product.
Data integrity and ALCOA+
Modern GMP rests on data integrity. The ALCOA+ principles — data that is Attributable, Legible, Contemporaneous, Original and Accurate, plus Complete, Consistent, Enduring and Available — define what trustworthy records look like. This is the backbone of digital R&D and audit readiness.
The regulatory framework
Several ICH guidelines shape GMP for peptides: ICH Q7 (GMP for active ingredients), Q2 (analytical validation), Q1A (stability), and Q3D (elemental impurities), among others. Together they define how a peptide API must be made, tested and documented.
Key point: GMP is a system, not a single test. You cannot “add GMP” at the end — it must be built into the process, the analytics and the documentation from the start.
The path through GMP
A typical program runs research material first, then transfers and scales into GMP as it approaches the clinic — the bridge described in scale-up from mg to kg and tech transfer to a CDMO. Along the way, analytical methods are validated, batch records are maintained, and the CMC section of the regulatory filing is assembled.
Why it matters
GMP is what lets a regulator — and ultimately a patient — trust your peptide. Choosing a partner with a mature quality system and real GMP experience is one of the highest-leverage decisions in a peptide program. See our guide on how to choose a peptide CDMO for how to evaluate it.